ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1001

Oral Collagen Type V Supplementation Inhibits Cartilage Degeneration in Experimental Arthritis

Lizandre Keren Silveira 1, José Eduardo Rodrigues 1, Silvana Atayde 1, Sergio Catanozi 1, Antonio dos Santos Filho 2, Vera Luiza Capelozzi 1, Ricardo Fuller 2, Ana Paula Velosa 2 and Walcy Teodoro1, 1Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR, Sao Paulo, Sao Paulo, Brazil, 2Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR, Sao Paulo, Sao Paulo, Brazil

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Animal models, Arthritis, cartilage, immune tolerance and collagen

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 11, 2019

Session Title: RA – Animal Models Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: It is known that collagen V (col V) can generate autoimmunity when exposed. In contrast, induction of tolerance with col V supplementation is able to protect affected tissues in autoimmune diseases. In an earlier study, we found that Col V oral supplementation reduced synovial inflammation in experimental arthritis but its action in cartilage is not known. To verify the action of oral Col V supplementation on cartilage in an experimental model of induced arthritis (IA).

Methods: Thirty 3 months-old male Lewis rats with weight of 220–240g were used. Arthritis was induced by intra-articular infiltration of 500μg of mBSA emulsified in complete Freund’s adjuvant (10μl) at days zero, 7 and 14. Oral Col V (isolated from bovine placenta) supplementation (500μg/300μl / day / 30 days) was daily performed until 30 days’ euthanasia in 10 animals (IA-Col V group). The other 10 did not receive oral Col V (IA group). Five rats received intra-articular saline (Sal group) and 5 received only oral Col V (Col V). Morphological and histomorphometric analyses were performed after Safranin-O/Fast Green, immunofluorescence and immunohistochemistry staining with Image-Pro Plus6.0 software. Serum IL-1β, TNFα, IL-17, IL-10 and anti-Col V were measured. All the animals received human care in compliance with the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health. Ethics in Committee Research for Animal Studies approval number 295/12.

Results: In the IA-Col V group, cartilage showed neither cracks, nor chondrocyte organization, and the growth line was preserved compared to the IA group. There was no reduction in chondrocytes number in the IA-col V group (39.86±1.79 vs 25.35±4.62, p< 0.009), cartilage thickness (78.73±7.27 vs 52.52±5.74, p< 0.03), proteoglycans content (76.82±9.31 vs 25.45±1.23%, p< 0.0036), type II collagen content (76.99±1,339 vs 39.13±5,618 p< 0.0001) and apoptosis (21.85±6.92 vs 71.69±10.46) compared to the IA group. In addition, there was lower serum expression in the IA-col V group of IL-1β (4.28±4.75 vs 21.96±2.29, p< 0.0001), TNFα (1.70 ± 0.51 vs 1.76 ± 0.39, p< 0.0001), IL-17 (2.19±0.50 vs 27.24±10.65, p< 0.0001) and IL-10 (0.13±0.03 vs 27.95±17.11, p< 0.0001) compared to the IA group. Furthermore, the IA group presented serum anti-collagen V. The results of the Sal and Col V groups were similar to those of the IA-Col V group for every parameter.

Conclusion: The oral collagen V supplementation avoided the degradation of cartilage in an experimental arthritis model and may represent a new therapeutic option for this condition.


Disclosure: L. Silveira, None; J. Rodrigues, None; S. Atayde, None; S. Catanozi, None; A. dos Santos Filho, None; V. Capelozzi, None; R. Fuller, None; A. Velosa, None; W. Teodoro, None.

To cite this abstract in AMA style:

Silveira L, Rodrigues J, Atayde S, Catanozi S, dos Santos Filho A, Capelozzi V, Fuller R, Velosa A, Teodoro W. Oral Collagen Type V Supplementation Inhibits Cartilage Degeneration in Experimental Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/oral-collagen-type-v-supplementation-inhibits-cartilage-degeneration-in-experimental-arthritis/. Accessed April 13, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/oral-collagen-type-v-supplementation-inhibits-cartilage-degeneration-in-experimental-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.